+ Follow PULMONARY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 159032
[Title] => Four doctors recognized for initiatives versus COPD
[Summary] => The COPD Foundation of the Philippines, in cooperation with the Boehringer-Ingelheim Medical Sciences Foundation (BIMSF), recognized the initiatives of four doctors and their medical institutions by honoring them with the first ever COPD Award for Service during the recent annual convention of the Philippine College of Chest Physicians.
[DatePublished] => 2002-04-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 155682
[Title] => Clot-dissolving therapy improves heart patients
[Summary] => ATLANTA, Georgia – Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed.
Patients who benefited from the treatment had signs of right-heart strain at presentation. Their hearts were laboring to function despite the presence of clots obstructing the pulmonary arteries, but the patients appeared hemodynamically stable or they had normal blood pressure.
[DatePublished] => 2002-04-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PULMONARY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 159032
[Title] => Four doctors recognized for initiatives versus COPD
[Summary] => The COPD Foundation of the Philippines, in cooperation with the Boehringer-Ingelheim Medical Sciences Foundation (BIMSF), recognized the initiatives of four doctors and their medical institutions by honoring them with the first ever COPD Award for Service during the recent annual convention of the Philippine College of Chest Physicians.
[DatePublished] => 2002-04-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 155682
[Title] => Clot-dissolving therapy improves heart patients
[Summary] => ATLANTA, Georgia – Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed.
Patients who benefited from the treatment had signs of right-heart strain at presentation. Their hearts were laboring to function despite the presence of clots obstructing the pulmonary arteries, but the patients appeared hemodynamically stable or they had normal blood pressure.
[DatePublished] => 2002-04-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
